Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 4/20 | 0.46 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.46 |
| ▸ | HMGCR | P04035 | 2/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | TERT | O14746 | 3/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.41 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | FABP4 | P15090 | 2/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.41 |
| ▸ | PPARG | P37231 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | PPARD | Q03181 | 2/20 | 0.41 |
| ▸ | PPARA | Q07869 | 2/20 | 0.41 |
| ▸ | GMNN | O75496 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11511228 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL3924992 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL887671 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL14809663 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL5872440 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL8374816 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL5521453 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL6880256 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL20482020 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT | |
| SCHEMBL9338672 | 1.00 | FAAH (0.46) | FAAHTRPV1HMGCRTSHRTERT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-05-09 | — | — | US | disclosed |
| EP-0885405-B1 | PHOTORESIST COMPOSITIONS COMPRISING POLYCYCLIC POLYMERS WITH ACID LABILE PENDANT GROUPS | SUMITOMO BAKELITE CO (JP) | 2005-06-08 | — | — | EP | disclosed |
| US-6790579-B1 | PHOTOACID INITIATOR GENERATES ACID EFFECTING POLARITY CHANGE RENDERING POLYMER WATER SOLUBLE IN AREAS EXPOSED TO IMAGING SOURCE; INTEGRATED CIRCUITS, SEMICONDUCTORS | SUMITOMO BAKELITE CO., LTD. (JP) | 2004-09-14 | — | — | US | disclosed |
| US-6723486-B2 | POLYMERIZING AT LEAST TWO TYPES OF POLYCYCLIC (NORBORNENE) MONOMERS ONE OF WHICH CONTAINING A PENDANT ACID LABILE GROUP AND ANOTHER OF WHICH CONTAINING A PENDNT POLAR FUNCTIONAL GROUP USING A GROUP 8 TRANSITION METAL CATALYST | SUMITOMO BAKELITE CO., LTD. (JP) | 2004-04-20 | — | — | US | disclosed |
| EP-0862589-B1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING SILYL FUNCTIONAL GROUPS | SUMITOMO BAKELITE CO (JP) | 2004-02-18 | — | — | EP | disclosed |
| EP-1157058-B1 | METHOD OF PREPARING NORBORNENE SULFONAMIDE POLYMERS | SUMITOMO BAKELITE CO (JP) | 2003-06-25 | — | — | EP | disclosed |
| US-20020128408-A1 | Photoresist compositions comprising polycyclic polymers with acid labile pendant groups | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2002-09-12 | — | — | US | disclosed |
| US-6420503-B1 | POLYCARBONS/OTHER/ | SUMITOMO BAKELITE CO. LTD. (JP) | 2002-07-16 | — | — | US | disclosed |
| EP-0906588-B1 | PHOTODEFINABLE DIELECTRIC COMPOSITIONS | GOODRICH CO B F (US) | 2002-03-27 | — | — | EP | disclosed |
| EP-1157058-A1 | METHOD OF PREPARING NORBORNENE SULFONAMIDE POLYMERS | The B.F. Goodrich Company (US) | 2001-11-28 | — | — | EP | disclosed |
| WO-1997033198-A1 | PHOTORESIST COMPOSITIONS COMPRISING POLYCYCLIC POLYMERS WITH ACID LABILE PENDANT GROUPS | THE B.F. GOODRICH COMPANY (US) | 1997-09-12 | — | — | WO | disclosed |
| WO-1997020871-A2 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING SILYL FUNCTIONAL GROUPS | THE B.F. GOODRICH COMPANY (US) | 1997-06-12 | — | — | WO | disclosed |
| EP-0758657-A2 | Addition polymers derived from norbornene-functional monomers and process therefor | The B.F. Goodrich Company (US) | 1997-02-19 | — | — | EP | disclosed |
| WO-1996037529-A1 | HOMOPOLYMERS AND COPOLYMERS OF CATIONICALLY POLYMERIZABLE MONOMERS AND METHOD OF THEIR PREPARATION | THE B.F. GOODRICH COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |
| WO-1996037526-A1 | ADDITION POLYMERS OF POLYCYCLOOLEFINS CONTAINING FUNCTIONAL SUBSTITUENTS | THE B.F. GOODRICH COMPANY (US) | 1996-11-28 | — | — | WO | disclosed |
| US-5571881-A | Addition polymers derived from norbornene-functional monomers and process therefor | THE B. F. GOODRICH COMPANY (US) | 1996-11-05 | — | — | US | disclosed |
| US-5569730-A | HAVING TERMINAL END GROUP DERIVED FROM CHAIN TRANSFER AGENT CONTAINING TERMINAL OLEFINIC DOUBLE BOND | THE B. F. GOODRICH COMPANY (US) | 1996-10-29 | — | — | US | disclosed |
| EP-0729480-A1 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | The B.F. Goodrich Company (US) | 1996-09-04 | — | — | EP | disclosed |
| WO-1995014048-A9 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | — | 1995-07-27 | — | — | WO | disclosed |
| WO-1995014048-A1 | ADDITION POLYMERS DERIVED FROM NORBORNENE-FUNCTIONAL MONOMERS AND PROCESS THEREFOR | THE B.F. GOODRICH COMPANY (US) | 1995-05-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11644753-B2 | Resist composition and patterning process | HNRNPU, NSUN2, HNRNPR | FAAH 3439/4885TRPV1 2776/4885HMGCR 3732/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.